Juan Delgado-Moreira, the Co-Chief Executive Officer of $HLNE, bought 4,008 shares of the company on 11-07-2025 for an estimated $520,398. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.3%. Following this trade, they now own 1,310,455 shares of this class of $HLNE stock.
$HLNE Insider Trading Activity
$HLNE insiders have traded $HLNE stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HLNE stock by insiders over the last 6 months:
- RIVER 5 LTD FRENCH sold 150,000 shares for an estimated $21,976,500
- JUAN DELGADO-MOREIRA (Co-Chief Executive Officer) has made 2 purchases buying 8,000 shares for an estimated $1,042,831 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HLNE Hedge Fund Activity
We have seen 192 institutional investors add shares of $HLNE stock to their portfolio, and 202 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 1,047,603 shares (-19.8%) from their portfolio in Q2 2025, for an estimated $148,885,338
- CITADEL ADVISORS LLC added 647,523 shares (+1325.7%) to their portfolio in Q2 2025, for an estimated $92,025,968
- FRED ALGER MANAGEMENT, LLC removed 518,118 shares (-82.9%) from their portfolio in Q2 2025, for an estimated $73,634,930
- WASATCH ADVISORS LP removed 497,077 shares (-25.0%) from their portfolio in Q2 2025, for an estimated $70,644,583
- INVESCO LTD. removed 395,975 shares (-21.7%) from their portfolio in Q2 2025, for an estimated $56,275,967
- WELLINGTON MANAGEMENT GROUP LLP removed 290,789 shares (-17.1%) from their portfolio in Q2 2025, for an estimated $41,326,932
- CHAMPLAIN INVESTMENT PARTNERS, LLC added 278,630 shares (+36.7%) to their portfolio in Q2 2025, for an estimated $39,598,895
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HLNE Analyst Ratings
Wall Street analysts have issued reports on $HLNE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 11/06/2025
- Oppenheimer issued a "Outperform" rating on 10/14/2025
- BMO Capital issued a "Outperform" rating on 10/03/2025
To track analyst ratings and price targets for $HLNE, check out Quiver Quantitative's $HLNE forecast page.
$HLNE Price Targets
Multiple analysts have issued price targets for $HLNE recently. We have seen 7 analysts offer price targets for $HLNE in the last 6 months, with a median target of $158.0.
Here are some recent targets:
- Kyle Voigt from Keefe, Bruyette & Woods set a target price of $158.0 on 11/06/2025
- Michael Cyprys from Morgan Stanley set a target price of $154.0 on 10/21/2025
- Chris Kotowski from Oppenheimer set a target price of $181.0 on 10/14/2025
- Brennan Hawken from BMO Capital set a target price of $150.0 on 10/03/2025
- Alexander Blostein from Goldman Sachs set a target price of $162.0 on 09/18/2025
- Kenneth Worthington from JP Morgan set a target price of $145.0 on 07/23/2025
- Michael Brown from Wells Fargo set a target price of $162.0 on 07/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
